TP53 and myelodysplastic syndrome: It is of interest to note that t-MDS exhibit a markedly higher frequency of TP53 and PPM1D mutations and a markedly lower frequency of ASXL1, U2AF1 and SRFSF2 mutations compared to p-MDS [86].